Infectech Corp
About Infectech Corp
Infectech specializes in the development and production of diagnostic kits used in the rapid identification of disease-causing pathogens. Infectech's patented and proprietary biotechnology identifies some of the deadliest pathogens known to man, including those associated with Pseudomonas, the major cause of death in intensive care and burn units, Mycobacterium avium intracellulare (MAI), a bacterial infection most associated with AIDS patients, and Mycrobacterium tuberculosis, the bacteria responsible for the tuberculosis infection, termed one of the deadliest infections in the world. Some of these bacteria are considered to be potential weapons in bioterrorism. Infectech's technology could allow for the rapid identification of these microbes and also provide good information on antibiotic treatment options.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
Canonical: https://fsome.com/organization/infectech-corp-1561806 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.